| PERIOD ENDING | 26-Sep-09 | 27-Jul-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 1,736,149 | 1,776,813 | 1,698,102 | 1,876,991 | | Cost of Revenue | 1,551,511 | 1,593,399 | 1,599,874 | 1,960,373 | | | Gross Profit | 172,174 | 183,414 | 98,228 | (83,382) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 57,496 | 74,818 | 78,356 | 92,437 | | Non Recurring | 97,752 |
-
| (435) | 2,422 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 116,665 | 108,596 | 20,307 | (178,241) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 65,642 | (15,958) | (30,306) | (11,268) | | Earnings Before Interest And Taxes | 95,032 | 92,638 | (9,999) | (189,509) | | Interest Expense | 37,074 | 38,843 | 46,443 | 39,569 | | Income Before Tax | 57,958 | 53,795 | (56,442) | (229,078) | | Income Tax Expense | (24,766) | 555 | 2,347 | 278 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 82,724 | 53,240 | (58,789) | (229,356) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 25 | 574 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 82,724 | 53,240 | (58,764) | (228,782) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $82,724 | $53,240 | ($58,764) | ($228,782) |
|
0.50% Nasdaq 0.00%
Income Statement
